Myasthenia Gravis Trial, Recruiting NCT06241521 Sponsor: Huashan Hospital Condition: Myasthenia Gravis
Back to Myasthenia Gravis

Myasthenia Gravis Trial, Recruiting

NCT06241521
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have muscle weakness that comes and goes, affecting muscles such as those controlling your eyes, swallowing, speaking, or moving your limbs — and this weakness tends to be worse in the morning and gets better with rest, but worse with continued activity.
  • You (or your legal guardian, if applicable) are able to understand and sign a consent form agreeing to take part.
  • At least one of the following also applies to you:
    • A special test called a "Tensilon test" (a medication test used to check for this type of muscle weakness) came back positive.
    • Nerve and muscle tests showed specific abnormal patterns, such as a drop in muscle electrical response during repeated nerve stimulation, or unusual timing variations detected during a single-fiber muscle test (confirm with trial site).
    • A blood test showed the presence of certain antibodies linked to this condition (called AChR, MuSK, or LRP4 antibodies).

Who may not be able to join:

  • People who have a mental health condition that would prevent them from cooperating with the study.
  • People who have serious problems with multiple organs or are in a very critical medical state, making it impossible to complete the necessary assessments and medical history collection.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86 2152889999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 February 2034

Where this trial is recruiting

🇨🇳 China

Primary endpoints

MSE proportion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov